Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

German labs sector ‘to grow strongly’

Opportunities for consolidation in the German diagnostic labs sector have almost dried up, according to a large lab operator. But the market as a whole will continue to grow strongly post-Covid, with revenue up as much as 4-5% per annum, he said.
August 26, 2022

KKR exits Max Healthcare

US private equity player KKR has solid its entire stake in India-based hospital chain Max Healthcare, marking its exit from the group, for around Rs9,200 crore. The deal marks its largest exit from an Indian firm, and is the largest single block deal done by any PE firm in India.
August 19, 2022

Lusiadas deal still on as seller carries cost of muti-million fine

The planned acquisition of Lusiadas Saude, Portugal's third largest hospital group, by France's third largest hospital group Vivalto Sante, will not be impacted by the €34.2m fine that has been handed to Lusiadas by Portugal's competition authority.
August 18, 2022

KKR may switch to private credit to finance IVI RMA takeover

Facing an increasingly volatile market, American buyout / investment firm KKR may switch to direct lenders to finance its acquisition of fertility company IVI RMA Global, despite agreeing €800m of underwritten financing from four investment banks.
August 18, 2022

Four Seasons seller happy to split group for sale

Potential buyers of Four Seasons Health Care Group’s (FSHC) 110 homes must place their bids before the end of September, insists Christie & Co, the business broker in charge of the sale.
August 16, 2022

Ramsay deal at risk due to French connection

The US$15bn KKR acquisition of Australia-based Ramsay may not go ahead, owing to consistent problems with the hospital group’s French subsidiary. HBI chats to an Australian analyst to find out more.
August 12, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us